Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections (CLOXECO): a quasi-experimental study
A kidney-sparing protocol for MSSA BSI based on systematic use of cefazolin in patients with AKI risk factor, and lower ASP doses, was associated with similar efficacy and lower risk of AKI and dialysis requirements.
Authors
- Agathe Delbove (ORCID: https://orcid.org/0000-0003-0170-9508)
- Marie Gousseff (ORCID: https://orcid.org/0000-0001-6341-572X)
- Huw Houssemayne du Boulay
- Patrick J. Babin (ORCID: https://orcid.org/0000-0002-7411-2297)
- F. Lemaı̂tre (ORCID: https://orcid.org/0000-0002-0908-3629)
- Anne Cady
- Pierre Tattevin (ORCID: https://orcid.org/0000-0003-3617-5411)
- Jean-Baptiste Gouin
- Yoann Crabol
- Mauriac Akoha
Institutions
- Centre hospitalier Bretagne Atlantique (FR)
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1093/jac/dkaf062
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00